CUSHING SYNDROME IN CHILDREN DUE TO PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE: A RARE CASE REPORT

Lan Nguyễn Hoàng1, Thao Bui Phuong1, Ngoc Can Thi Bich1, Ngoc Le Kim1, Hoan Vu Manh1, Van Nguyen Anh1, Dung Vu Chi1
1 Vietnam National Children’s Hospital

##plugins.themes.vojs.article.main##

Abstract

Cushing syndrome in pediatric patients typically presents with characteristic clinical features; however, identifying the underlying etiology remains challenging, particularly in rare forms of the disease. Primary Pigmented Nodular Adrenocortical Disease (PPNAD) is an uncommon cause of ACTH-independent Cushing syndrome. Diagnosis is often difficult due to the presence of small adrenal lesions and non-specific imaging findings in the early stages.We report the case of a 7-year-old girl with a 3-year history of rapid weight gain, progressive facial rounding, and hirsutism, who had been evaluated at multiple medical centers without a definitive diagnosis. Upon admission to the National Children’s Hospital, the patient presented with classical features of Cushing syndrome accompanied by severe, difficult-to-control hypertension. Endocrine evaluation confirmed ACTH-independent hypercortisolism. Abdominal computed tomography revealed bilateral adrenal abnormalities suggestive of PPNAD. The patient subsequently underwent bilateral adrenalectomy, and histopathological examination confirmed the diagnosis of PPNAD. This case highlights the importance of considering PPNAD in pediatric patients with ACTH-independent Cushing syndrome to facilitate early diagnosis and prevent irreversible complications.

##plugins.themes.vojs.article.details##

References

1. Sun J, Ding L, He L et al. The clinical characteristics and pathogenic variants of primary pigmented nodular adrenocortical disease in 210 patients: a systematic review. Front Endocrinol 2024;15:1356870. https://doi.org/10.3389/fendo.2024.1356870
2. Stratakis CA, Kirschner LS, Carney JA. Clinical and Molecular Features of the Carney Complex: Diagnostic Criteria and Recommendations for Patient Evaluation. J Clin Endocrinol Metab 2001;86(9):4041-4046. https://doi.org/10.1210/jcem.86.9.7903
3. Manipadam MT, Abraham R, Sen S, Simon A. Primary pigmented nodular adrenocortical disease. J Indian Assoc Pediatr Surg 2011;16(4):160-162. https://doi.org/10.4103/0971-9261.86881
4. Sandrini F, Stratakis C. Clinical and molecular genetics of primary pigmented nodular adrenocortical disease. Arq Bras Endocrinol Metabol 2004;48(5):637-641. https://doi.org/10.1590/S0004-27302004000500007
5. Elshimy G, Rout P. Carney Complex. In: StatPearls. StatPearls Publishing; 2026. Accessed June 1, 2026. http://www.ncbi.nlm.nih.gov/books/NBK507877/
6. Memon SS, Thakkar K, Patil V et al. Primary pigmented nodular adrenocortical disease (PPNAD): single centre experience. J Pediatr Endocrinol Metab 2019;32(4):391-397. https://doi.org/10.1515/jpem-2018-0413
7. Paradoxical Response to Dexamethasone in the Diagnosis of Primary Pigmented Nodular Adrenocortical Disease. Annals of Internal Medicine. Published online August 15, 2000. Accessed June 1, 2026. https://www.acpjournals.org/doi/10.7326/0003-4819-131-8-199910190-00006
8. Bourdeau I, Lacroix A, Schürch W et al. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor. J Clin Endocrinol Metab 2003;88(8):3931-3937. https://doi.org/10.1210/jc.2002-022001